跳至主要内容
临床试验/NCT03160482
NCT03160482已完成不适用

Evaluation of PACE4 Isoforms as Biomarkers in Thyroid Cancer

Robert Day1 个研究点 分布在 1 个国家目标入组 39 人开始时间: 2017年5月15日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
Robert Day
入组人数
39
试验地点
1
主要终点
Expression pattern of the studied protein convertase

研究概览

简要总结

The investigation of thyroid nodules is limited by the fact that up to 49% of the fine needle aspirations (FNA) performed are of "indeterminate cytological signification". Moreover, no fully reliable molecular marker for thyroid cancer have been described. The goal of this project is to study the expression of a specific kind of protein convertase in benign and in malignant thyroid nodules to determine its potential as a biomarker.

详细描述

Patients that underwent thyroidectomy at the CIUSSS de l'Estrie-CHUS will be recruited and classified according to the pathological diagnosis. An immunohistochemistry technique, developed and calibrated for the specific protein convertase studied, will be undertaken. Results will be interpreted by a specialized pathologist.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Cross Sectional

入排标准

年龄范围
18 Years 至 100 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Men of women, aged 18-100 y.-o.
  • History of subtotal or total thyroidectomy at the "Centre intégré universitaire de santé et de services sociaux de l'Estrie - Centre hospitalier universitaire de Sherbrooke" (CIUSSS de l'Estrie - CHUS) between January 2010 and May 2016.

排除标准

  • Refusal to participate to the study.
  • Unavailability of the formalin-fixed, paraffin-embedded tissues.
  • Uncertain pathological diagnosis.

结局指标

主要结局

Expression pattern of the studied protein convertase

时间窗: Trough study completion, an average of 1 year after the patients have been operated.

Horseradish peroxidase staining with specific antibodies.

次要结局

未报告次要终点

研究者

发起方
Robert Day
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Robert Day

PhD

Université de Sherbrooke

研究点 (1)

Loading locations...

相似试验

PACE4 in Thyroid Cancer | 临床试验